Literature DB >> 19509179

Global gene expression analysis of reactive stroma in prostate cancer.

Olga Dakhova1, Mustafa Ozen, Chad J Creighton, Rile Li, Gustavo Ayala, David Rowley, Michael Ittmann.   

Abstract

PURPOSE: Marked reactive stroma formation, designated as grade 3 reactive stroma, is associated with poor outcome in clinically localized prostate cancer. To understand the biological processes and signaling mechanisms underlying the formation of such reactive stroma, we carried out microarray gene expression analysis of laser-captured reactive stroma and matched normal stroma. EXPERIMENTAL
DESIGN: Seventeen cases of reactive stroma grade 3 cancer were used to laser-capture tumor and normal stroma. Expression analysis was carried out using Agilent 44K arrays. Up-regulation of selected genes was confirmed by quantitative reverse transcription-PCR. Expression data was analyzed to identify significantly up- and down-regulated genes, and gene ontology analysis was used to define pathways altered in reactive stroma.
RESULTS: A total of 544 unique genes were significantly higher in the reactive stroma and 606 unique genes were lower. Gene ontology analysis revealed significant alterations in a number of novel processes in prostate cancer reactive stroma, including neurogenesis, axonogenesis, and the DNA damage/repair pathways, as well as evidence of increases in stem cells in prostate cancer reactive stroma.
CONCLUSIONS: Formation of reactive stroma in prostate cancer is a dynamic process characterized by significant alterations in growth factor and signal transduction pathways and formation of new structures, including nerves and axons.

Entities:  

Mesh:

Year:  2009        PMID: 19509179      PMCID: PMC2734921          DOI: 10.1158/1078-0432.CCR-08-1899

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  53 in total

1.  Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation.

Authors:  Michael J Nemeth; Lilia Topol; Stacie M Anderson; Yingzi Yang; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

2.  Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation.

Authors:  Chad J Creighton; Jennifer L Bromberg-White; David E Misek; David J Monsma; Frank Brichory; Rork Kuick; Thomas J Giordano; Weimin Gao; Gilbert S Omenn; Craig P Webb; Samir M Hanash
Journal:  Mol Cancer Res       Date:  2005-03       Impact factor: 5.852

3.  Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.

Authors:  Nobuyuki Yanagisawa; Rile Li; David Rowley; Hao Liu; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Gustavo E Ayala
Journal:  Hum Pathol       Date:  2008-02       Impact factor: 3.466

4.  Cancer-related axonogenesis and neurogenesis in prostate cancer.

Authors:  Gustavo E Ayala; Hong Dai; Michael Powell; Rile Li; Yi Ding; Thomas M Wheeler; David Shine; Dov Kadmon; Timothy Thompson; Brian J Miles; Michael M Ittmann; David Rowley
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

5.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 6.  ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.

Authors:  M F Lavin
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

7.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

8.  Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors.

Authors:  John Barlow; David Yandell; Donald Weaver; Theresa Casey; Karen Plaut
Journal:  Breast Cancer Res Treat       Date:  2003-05       Impact factor: 4.872

9.  Development of human protein reference database as an initial platform for approaching systems biology in humans.

Authors:  Suraj Peri; J Daniel Navarro; Ramars Amanchy; Troels Z Kristiansen; Chandra Kiran Jonnalagadda; Vineeth Surendranath; Vidya Niranjan; Babylakshmi Muthusamy; T K B Gandhi; Mads Gronborg; Nieves Ibarrola; Nandan Deshpande; K Shanker; H N Shivashankar; B P Rashmi; M A Ramya; Zhixing Zhao; K N Chandrika; N Padma; H C Harsha; A J Yatish; M P Kavitha; Minal Menezes; Dipanwita Roy Choudhury; Shubha Suresh; Neelanjana Ghosh; R Saravana; Sreenath Chandran; Subhalakshmi Krishna; Mary Joy; Sanjeev K Anand; V Madavan; Ansamma Joseph; Guang W Wong; William P Schiemann; Stefan N Constantinescu; Lily Huang; Roya Khosravi-Far; Hanno Steen; Muneesh Tewari; Saghi Ghaffari; Gerard C Blobe; Chi V Dang; Joe G N Garcia; Jonathan Pevsner; Ole N Jensen; Peter Roepstorff; Krishna S Deshpande; Arul M Chinnaiyan; Ada Hamosh; Aravinda Chakravarti; Akhilesh Pandey
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

10.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029

View more
  77 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

2.  Modeling stromal-epithelial interactions in disease progression.

Authors:  Douglas W Strand; Simon W Hayward
Journal:  Discov Med       Date:  2010-06       Impact factor: 2.970

3.  Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens.

Authors:  Jing Chen; Jiefeng Xi; Yuan Tian; George Steven Bova; Hui Zhang
Journal:  Proteomics       Date:  2013-07-05       Impact factor: 3.984

Review 4.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

5.  RET Signaling in Prostate Cancer.

Authors:  Kechen Ban; Shu Feng; Longjiang Shao; Michael Ittmann
Journal:  Clin Cancer Res       Date:  2017-05-10       Impact factor: 12.531

6.  Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.

Authors:  Jennifer L Gregg; Kathleen E Brown; Eric M Mintz; Helen Piontkivska; Gail C Fraizer
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

7.  The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae.

Authors:  Daniel Drömann; Jan Rupp; Kristina Rohmann; Sinia Osbahr; Artur J Ulmer; Sebastian Marwitz; Kristina Röschmann; Mahdi Abdullah; Holger Schultz; Ekkehard Vollmer; Peter Zabel; Klaus Dalhoff; Torsten Goldmann
Journal:  Respir Res       Date:  2010-05-31

8.  Protein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues.

Authors:  Zahraa I Khamis; Kenneth A Iczkowski; Ziad J Sahab; Qing-Xiang Amy Sang
Journal:  J Cancer       Date:  2010-06-15       Impact factor: 4.207

9.  Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.

Authors:  Shu Feng; Olga Dakhova; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

Review 10.  Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.

Authors:  Masayuki Shimoda; Kieran T Mellody; Akira Orimo
Journal:  Semin Cell Dev Biol       Date:  2009-10-24       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.